Michael Steiner - Dr Ing Member RD
DRPRY Stock | 6.45 0.14 2.22% |
Insider
Michael Steiner is Member RD of Dr Ing hc
Age | 59 |
Phone | 49 711 911 0 |
Web | https://www.porsche.com/international |
Michael Steiner Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Steiner against Dr Ing pink sheet is an integral part of due diligence when investing in Dr Ing. Michael Steiner insider activity provides valuable insight into whether Dr Ing is net buyers or sellers over its current business cycle. Note, Dr Ing insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dr Ing'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Steiner over six months ago Disposition of 54824 shares by Michael Steiner of EVI Industries at 14.67 subject to Rule 16b-3 | ||
Michael Steiner over a year ago EVI Industries exotic insider transaction detected | ||
Michael Steiner over a year ago Sale by Michael Steiner of 1300 shares of EVI Industries |
Similar Executives
Showing other executives | INSIDER Age | ||
Scott Hamilton | iHeartMedia | 53 | |
Bradford Tobin | Mediaco Holding | 41 | |
Wendy Goldberg | iHeartMedia | 59 | |
Rdiger Bss | ProSiebenSat1 Media AG | N/A | |
Robert Pittman | iHeartMedia | 69 | |
Wolfgang Link | ProSiebenSat1 Media AG | 55 | |
Scott Esq | Mediaco Holding | 61 | |
Ann Beemish | Mediaco Holding | 51 | |
Stefanie RuppMenedetter | ProSiebenSat1 Media AG | N/A | |
Susanne Brieu | ProSiebenSat1 Media AG | N/A | |
Jeff Howard | iHeartMedia | N/A | |
Michael McGuinness | iHeartMedia | 46 | |
Kyla Mullins | ITV PLC ADR | N/A | |
Tracy Cleeton | Saga Communications | N/A | |
Bjrn Bauer | RTL Group SA | 43 | |
Bert Habets | ProSiebenSat1 Media AG | 52 | |
Steve Mills | iHeartMedia | 64 | |
Gayle Troberman | iHeartMedia | N/A | |
Sallie Kimbrough | Cumulus Media Class | N/A | |
Christina Albee | Cumulus Media Class | N/A | |
General Heggen | RTL Group SA | 55 |
Dr Ing hc Leadership Team
Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DRPRY. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lutz Meschke, CFO Board | ||
Michael Steiner, Member RD | ||
Albrecht Reimold, Member Logistics | ||
Detlev Platen, Head Board | ||
Barbara Frenkel, Member Procurement | ||
Andreas Haffner, Member Affairs | ||
Oliver Blume, Chairman CEO |
DRPRY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dr Ing a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Profit Margin | 0.14 % | |||
Operating Margin | 0.20 % | |||
Revenue | 36.76 B | |||
Gross Profit | 8.99 B | |||
EBITDA | 9.38 B | |||
Net Income | 4.03 B | |||
Book Value Per Share | 25.19 X | |||
Cash Flow From Operations | 6.42 B | |||
Number Of Employees | 36.52 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DRPRY Pink Sheet Analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.